Prati
Magdalena G Krzystolik
Magdalena G Krzystolik
Assistant Professor, Retina Service, Mass Eye and Ear, Boston, MA
Potvrđena adresa e-pošte na meei.harvard.edu
Naslov
Citirano
Citirano
Godina
Prevention of experimental choroidal neovascularization with intravitreal anti–vascular endothelial growth factor antibody fragment
MG Krzystolik, MA Afshari, AP Adamis, J Gaudreault, ES Gragoudas, ...
Archives of ophthalmology 120 (3), 338-346, 2002
8042002
Anti‐vascular endothelial growth factor for neovascular age‐related macular degeneration
SD Solomon, K Lindsley, SS Vedula, MG Krzystolik, BS Hawkins
Cochrane Database of Systematic Reviews, 2014
6382014
Antiangiogenic therapy with anti‐vascular endothelial growth factor modalities for neovascular age‐related macular degeneration
SS Vedula, M Krzystolik
Cochrane Database of Systematic Reviews, 2008
1482008
The ocular manifestations and transmission of COVID-19: recommendations for prevention
DM Dockery, SG Rowe, MA Murphy, MG Krzystolik
The Journal of emergency medicine 59 (1), 137-140, 2020
1472020
Treatment regimens for administration of anti‐vascular endothelial growth factor agents for neovascular age‐related macular degeneration
E Li, S Donati, KB Lindsley, MG Krzystolik, G Virgili
Cochrane Database of Systematic Reviews, 2020
1082020
Predictors of visual outcome and choroidal neovascular membrane formation after traumatic choroidal rupture
CS Ament, DN Zacks, AM Lane, M Krzystolik, DJ D’Amico, S Mukai, ...
Archives of ophthalmology 124 (7), 957-966, 2006
922006
Intravitreal bevacizumab versus ranibizumab for treatment of neovascular age-related macular degeneration: findings from a cochrane systematic review
SD Solomon, KB Lindsley, MG Krzystolik, SS Vedula, BS Hawkins
Ophthalmology 123 (1), 70-77. e1, 2016
802016
Complications of intraocular tamponade: silicone oil versus intraocular gas
MG Krzystolik, DJ D'Amico
International ophthalmology clinics 40 (1), 187-200, 2000
562000
Pegaptanib as an adjunctive treatment for complicated neovascular diabetic retinopathy
MG Krzystolik, T Filippopoulos, JF Ducharme, JI Loewenstein
Archives of Ophthalmology 124 (6), 920-921, 2006
312006
Antiangiogenic therapy with interferon alfa for neovascular age‐related macular degeneration
U Reddy, M Krzystolik
Cochrane Database of Systematic Reviews, 2006
202006
Diagnostic and therapeutic challenges of sarcoidosis
M Krzystolik, WJ Power, CS Foster
International ophthalmology clinics 38 (1), 61-76, 1998
191998
EXOGENOUSASPERGILLUS NIGERENDOPHTHALMITIS IN A PATIENT WITH A FILTERING BLEB
MG KRZYSTOLIK, TA Ciulla, TM Topping, AS Baker
Retina 17 (5), 461-462, 1997
161997
Wyburn-Mason syndrome associated with cutaneous reactive angiomatosis and central retinal vein occlusion
AB Callahan, D Skondra, M Krzystolik, Y Yonekawa, D Eliott
Ophthalmic Surgery, Lasers and Imaging Retina 46 (7), 760-762, 2015
152015
Cost and selection of ophthalmic anti-vascular endothelial growth factor agents
E Li, PB Greenberg, I Voruganti, MG Krzystolik
RI Med J 99 (5), 15-17, 2016
122016
The use of mobile applications as low-vision aids: a pilot study
DMD COA, MG Krzystolik
Rhode Island Medical Journal 103 (8), 69-72, 2020
102020
Anterior-segment ultrasound biomicroscopy in a patient with AIDS and bilateral angle-closure glaucoma secondary to uveal effusions
MG Krzystolik, M Kuperwasser, RM Low, EB Dreyer
Archives of Ophthalmology 114 (7), 878-879, 1996
81996
Antiangiogenic agents as an adjunctive treatment for complicated neovascular glaucoma
T Filippopoulos, JF Ducharme, JI Loewenstein, MG Krzystolik
Investigative Ophthalmology & Visual Science 47 (13), 4476-4476, 2006
72006
Nurse-administered intravitreal injections: a systematic review
E Li, PB Greenberg, MG Krzystolik
Graefe's Archive for Clinical and Experimental Ophthalmology 253, 1619-1621, 2015
52015
A 5-year retrospective assessment of clinical presentation associated with sports injury in young people presenting to a tertiary eye center
DM Dockery, MA Harrington, MF Gardiner, MG Krzystolik
Journal of Pediatric Ophthalmology & Strabismus 58 (6), 377-384, 2021
42021
Treatment schedules for administration of anti-vascular endothelial growth factor agents for neovascular age-related macular degeneration
E Li, S Donati, G Virgili, MG Krzystolik
Cochrane Database of Systematic Reviews 2016 (5), CD012208, 2016
32016
Sustav trenutno ne može provesti ovu radnju. Pokušajte ponovo kasnije.
Članci 1–20